Cargando…

A Blind Spot in the Diagnostic Field: The Challenging Diagnosis of Tumefactive Multiple Sclerosis

Tumefactive Multiple Sclerosis (TMS) is a rare variant with 1 per 1000 cases of MS and 3 per million cases per year. TMS can mimic clinical and radiological features of a neoplasm, infarction, or abscess and therefore can be diagnostically challenging for clinicians. We present a clinical scenario o...

Descripción completa

Detalles Bibliográficos
Autores principales: Mando, Ramy, Muallem, Emile, Meka, Shaiva G., Berghea, Ramona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6040262/
https://www.ncbi.nlm.nih.gov/pubmed/30050706
http://dx.doi.org/10.1155/2018/6841291
_version_ 1783338823691796480
author Mando, Ramy
Muallem, Emile
Meka, Shaiva G.
Berghea, Ramona
author_facet Mando, Ramy
Muallem, Emile
Meka, Shaiva G.
Berghea, Ramona
author_sort Mando, Ramy
collection PubMed
description Tumefactive Multiple Sclerosis (TMS) is a rare variant with 1 per 1000 cases of MS and 3 per million cases per year. TMS can mimic clinical and radiological features of a neoplasm, infarction, or abscess and therefore can be diagnostically challenging for clinicians. We present a clinical scenario of a patient presenting with left homonymous hemianopia with atypical radiological features initially thought to be more consistent with neoplasm or infraction. Ultimately, biopsy was done which led to the diagnosis of tumefactive multiple sclerosis.
format Online
Article
Text
id pubmed-6040262
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-60402622018-07-26 A Blind Spot in the Diagnostic Field: The Challenging Diagnosis of Tumefactive Multiple Sclerosis Mando, Ramy Muallem, Emile Meka, Shaiva G. Berghea, Ramona Case Rep Neurol Med Case Report Tumefactive Multiple Sclerosis (TMS) is a rare variant with 1 per 1000 cases of MS and 3 per million cases per year. TMS can mimic clinical and radiological features of a neoplasm, infarction, or abscess and therefore can be diagnostically challenging for clinicians. We present a clinical scenario of a patient presenting with left homonymous hemianopia with atypical radiological features initially thought to be more consistent with neoplasm or infraction. Ultimately, biopsy was done which led to the diagnosis of tumefactive multiple sclerosis. Hindawi 2018-06-27 /pmc/articles/PMC6040262/ /pubmed/30050706 http://dx.doi.org/10.1155/2018/6841291 Text en Copyright © 2018 Ramy Mando et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Mando, Ramy
Muallem, Emile
Meka, Shaiva G.
Berghea, Ramona
A Blind Spot in the Diagnostic Field: The Challenging Diagnosis of Tumefactive Multiple Sclerosis
title A Blind Spot in the Diagnostic Field: The Challenging Diagnosis of Tumefactive Multiple Sclerosis
title_full A Blind Spot in the Diagnostic Field: The Challenging Diagnosis of Tumefactive Multiple Sclerosis
title_fullStr A Blind Spot in the Diagnostic Field: The Challenging Diagnosis of Tumefactive Multiple Sclerosis
title_full_unstemmed A Blind Spot in the Diagnostic Field: The Challenging Diagnosis of Tumefactive Multiple Sclerosis
title_short A Blind Spot in the Diagnostic Field: The Challenging Diagnosis of Tumefactive Multiple Sclerosis
title_sort blind spot in the diagnostic field: the challenging diagnosis of tumefactive multiple sclerosis
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6040262/
https://www.ncbi.nlm.nih.gov/pubmed/30050706
http://dx.doi.org/10.1155/2018/6841291
work_keys_str_mv AT mandoramy ablindspotinthediagnosticfieldthechallengingdiagnosisoftumefactivemultiplesclerosis
AT muallememile ablindspotinthediagnosticfieldthechallengingdiagnosisoftumefactivemultiplesclerosis
AT mekashaivag ablindspotinthediagnosticfieldthechallengingdiagnosisoftumefactivemultiplesclerosis
AT berghearamona ablindspotinthediagnosticfieldthechallengingdiagnosisoftumefactivemultiplesclerosis
AT mandoramy blindspotinthediagnosticfieldthechallengingdiagnosisoftumefactivemultiplesclerosis
AT muallememile blindspotinthediagnosticfieldthechallengingdiagnosisoftumefactivemultiplesclerosis
AT mekashaivag blindspotinthediagnosticfieldthechallengingdiagnosisoftumefactivemultiplesclerosis
AT berghearamona blindspotinthediagnosticfieldthechallengingdiagnosisoftumefactivemultiplesclerosis